AU2001280996A1 - Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke - Google Patents

Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke

Info

Publication number
AU2001280996A1
AU2001280996A1 AU2001280996A AU8099601A AU2001280996A1 AU 2001280996 A1 AU2001280996 A1 AU 2001280996A1 AU 2001280996 A AU2001280996 A AU 2001280996A AU 8099601 A AU8099601 A AU 8099601A AU 2001280996 A1 AU2001280996 A1 AU 2001280996A1
Authority
AU
Australia
Prior art keywords
tia
biomarkers
stroke
blood tests
multiple panel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280996A
Inventor
Svetlana A. Dambinova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Biotech Inc
Original Assignee
CIS Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Biotech Inc filed Critical CIS Biotech Inc
Publication of AU2001280996A1 publication Critical patent/AU2001280996A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
AU2001280996A 2000-08-04 2001-08-02 Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke Abandoned AU2001280996A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63274900A 2000-08-04 2000-08-04
US09/632,749 2000-08-04
US30129701P 2001-06-27 2001-06-27
US60/301,297 2001-06-27
PCT/US2001/024248 WO2002012892A2 (en) 2000-08-04 2001-08-02 Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke

Publications (1)

Publication Number Publication Date
AU2001280996A1 true AU2001280996A1 (en) 2002-02-18

Family

ID=26972282

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280996A Abandoned AU2001280996A1 (en) 2000-08-04 2001-08-02 Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke

Country Status (2)

Country Link
AU (1) AU2001280996A1 (en)
WO (1) WO2002012892A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896872B2 (en) 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
GB0203768D0 (en) * 2002-02-18 2002-04-03 Univ Geneve Diagnostic method for stroke
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
JP2008547002A (en) 2005-06-13 2008-12-25 シーアイエス バイオテック,インコーポレイティド Methods for diagnosing and treating cerebrovascular events based on NR2 peptides
JP2009503520A (en) * 2005-07-29 2009-01-29 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Beta-amyloid receptor and use thereof
CA2685382C (en) 2007-05-01 2023-02-21 The Regents Of The University Of California Methods for diagnosing ischemia
CA2804763C (en) 2010-07-14 2023-01-03 The Regents Of The University Of California Biomarkers for diagnosis of transient ischemic attacks
EP2593567B1 (en) 2010-07-15 2016-04-20 The Regents of The University of California Biomarkers for diagnosis of stroke and its causes
WO2012121978A2 (en) 2011-03-04 2012-09-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
GB2497138A (en) 2011-12-02 2013-06-05 Randox Lab Ltd Biomarkers for stroke and stroke subtype diagnosis.
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
EP2815237A4 (en) * 2012-02-15 2015-11-04 Basf Se Means and methods for assessing neuronal toxicity
JP6042968B2 (en) 2012-04-20 2016-12-14 ユセベ ファルマ ソシエテ アノニム How to treat Parkinson's disease
US20140274975A1 (en) * 2013-03-13 2014-09-18 Health Diagnostic Laboratory, Inc. Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance
GB201309928D0 (en) 2013-06-04 2013-07-17 Randox Lab Ltd Method
GB201619823D0 (en) 2016-11-23 2017-01-04 Randox Laboratories Ltd And Teoranta Randox GFAP accumulating stroke
RU2668534C1 (en) 2017-07-18 2018-10-01 Общество с ограниченной ответственностью "ДРД" Diagnostic kit of reagents for detecting chronic pathologies of the brain of ischemic genesis

Also Published As

Publication number Publication date
WO2002012892A2 (en) 2002-02-14
WO2002012892A3 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2001280996A1 (en) Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
AU2002246583A1 (en) Methods of manufacturing reagent test strips
AU2001271501A1 (en) Opposable-element chromatographic assay device for detection of analytes in whole blood samples
AU2002249819A1 (en) Measurement testing of blood specimens
AU2002224831A1 (en) Kit and method for determining multiple analytes
AU2002366046A1 (en) Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
WO2002041195A8 (en) Structural stress analysis
AU2003271679A1 (en) Laboratory workstation for providing samples
AU2001274829A1 (en) Method for detection of biological related materials using biomarkers
AU2003242251A1 (en) Kit for assay development and serial analysis
AU2002219789A1 (en) Methods for analyzing dynamic changes in cellular informatics
AU2001294872A1 (en) Methods and reagents for live-cell gene expression quantification
AU2002349119A1 (en) Movable sample holder
AU2002353443A1 (en) Kits and methods for preparing cell samples optimized for dual staining
AU2002328229A1 (en) Yeast proteome analysis
AU2001263771A1 (en) An assay method and kit for testing biological material for exposure to stress using biomarkers
AU2001277625A1 (en) Electrochemical strip test for small volumes
AU2003300109A1 (en) Rapid test for antibodies against hiv in urine
AU2002317672A1 (en) Method for the biochemical detection of analytes
GB0110172D0 (en) Improved analytical test approach for blood
AU2002310629A1 (en) Sample well plate
AU2001258819A1 (en) Kit for assaying saccharified protein
AU2002249789A1 (en) Methods and reagents for analysis of rna structure and function
AU2002222146A1 (en) Reagents and methods for use inn the detection of analytes
AU2002249465A1 (en) Improved analytical test approach for blood